Valuation dated 2026-01-28 for LISTD PRIVTE EQTY UCITS (ISIN IE0008ZGI5C1) reports a USD-denominated NAV with 10,591,022.0000 units and a NAV per unit of 34.2716 (published 29 Jan 2026 08:00 CET). This is a routine NAV disclosure for a private-equity UCITS, providing the latest per-unit valuation for investor mark-to-market, subscription and redemption reference.
Market structure: A steady NAV publication for a listed private‑equity UCITS signals continued demand for retail‑accessible private markets; winners are listed PE managers (BX, KKR, CG) and secondary market platforms that monetize illiquid assets, losers are small direct funds and levered BDCs that rely on short‑dated funding. Increased retail supply into UCITS can bid up entry valuations by ~5–15% over 6–12 months and reduces public alpha capture on exits, shifting fees/revenue toward scale managers. Risk assessment: Key tail risks are rapid NAV markdowns (>10–20%), gating or UCITS regulatory tightening, and a short‑term funding squeeze that forces asset sales; these would transmit to credit spreads and BDC equity within days–weeks. Immediate risk (0–30 days) is redemption shock around quarterly NAVs; medium (1–6 months) is multiple compression if rates stay elevated; long (6–24 months) is realization risk on exits reducing fee pools and AUM growth. Trade implications: Prefer liquid exposure to global asset managers (KKR, ticker KKR; Blackstone, BX) to capture fee growth and secondary trading spreads; underweight/hedge leveraged credit exposure (ARCC) and small BDCs. Use options to hedge funding‑sensitive credits (buy 3‑month put spreads on ARCC sized to 1–2% notional) and employ BX covered call overlays to finance carry while holding for 6–12 months. Contrarian angle: Consensus underestimates mark‑to‑model fragility — listed PE NAV stability can mask 10–25% unrealized losses if exit markets reprice; a benign view is underdone given crowded retail flows. Historical parallel: 2020 liquidity squeeze showed rapid public decoupling from private marks; a regulatory nudge (UCITS rule change) could force visible repricing and create a buying opportunity for quality GPs within 3–9 months.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00